Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Gross Margin (2016 - 2025)

Nephros has reported Gross Margin over the past 16 years, most recently at 58.38% for Q4 2025.

  • Quarterly results put Gross Margin at 58.38% for Q4 2025, down 557.0% from a year ago — trailing twelve months through Dec 2025 was 61.87% (up 28.0% YoY), and the annual figure for FY2025 was 61.87%, up 28.0%.
  • Gross Margin for Q4 2025 was 58.38% at Nephros, down from 61.19% in the prior quarter.
  • Over the last five years, Gross Margin for NEPH hit a ceiling of 64.67% in Q1 2025 and a floor of 31.63% in Q3 2022.
  • Median Gross Margin over the past 5 years was 58.64% (2023), compared with a mean of 56.97%.
  • Biggest five-year swings in Gross Margin: tumbled -2112bps in 2022 and later surged 2700bps in 2023.
  • Nephros' Gross Margin stood at 54.22% in 2021, then increased by 9bps to 58.99% in 2022, then grew by 5bps to 62.11% in 2023, then rose by 3bps to 63.95% in 2024, then decreased by -9bps to 58.38% in 2025.
  • The last three reported values for Gross Margin were 58.38% (Q4 2025), 61.19% (Q3 2025), and 63.25% (Q2 2025) per Business Quant data.